Vaxxas Inc. Initiates Research Project On Advancing Next Generation Technology For Polio Vaccine Delivery

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass. & BRISBANE, Queensland--(BUSINESS WIRE)--Vaxxas, a biotechnology company commercializing a novel vaccine delivery platform, today announced the initiation of a research project to evaluate Vaxxas' proprietary Nanopatchâ„¢ platform for delivery of polio vaccine. The Nanopatch induces robust immune system activation by targeting vaccine to the abundant immunological cells immediately below the surface of the skin.

Help employers find you! Check out all the jobs and post your resume.

Back to news